Catalyst Wire Dossier Catalyst Wire Dossier

Pyrimethamine

Pyrimethamine
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Pyrimethamine, covering 2008-03-04 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma [EARLY_Phase 1]

See pricing